Framingham Heart Study Database
Description
The Framingham Heart Study was started in 1948 under the direction of the National Heart Institute (now known as the National Heart, Lung, and Blood Institute). Since 1971, the Study has been conducted in collaboration with Boston University. The initial study recruited 5,209 men and women between 30 and 62 years of age. Researchers asked participants questions about their general health, medications (including beta-blockers and cholesterol medications, aspirin, diuretics, and many other kinds of over-the-counter and prescription drugs), and asked about illnesses, including cancer. Since 1948, participants have been assessed every two years, undergoing a detailed medical history, physical examination and laboratory tests. The Study currently is collecting information from second and third generations of the original cohort.
Data is available upon acceptance of a research proposal. Information on using data can be found at: http://www.nhlbi.nih.gov/about/framingham/policies/index.htm#repro.
Selected References
Etiology
Muscat JE, Dyer AM, Rosenbaum RE, Rigas B.
Nitric oxide-releasing medications and colorectal cancer risk: the framingham study.
Anticancer Res 2005 Nov-Dec;25(6C):4471-4.
|
